
GOODLIFE Healthcare is searching for late stage pharmaceutical therapies in endocrinology, urology and gynaecology. the company is especially interested in hormone replacement therapies (HRT) at the late or registered stage.
These opportunities will be added to other products in this field with the aim to circulate these therapies to selected professionals, with a primary aim to reach geographical regions of Belgium, The Netherlands and Luxembourg.
MBA Frits Rooth
Managing Director
GOODLIFE Healthcare is involved primarily in the production of medicines for disorders of endocrinology, urology and gynaecology.
View profile